Collateralization of the upper extremity lymphatic system after axillary lymph node dissection.
anatomy
axillary lymph node dissection
breast cancer
lymphatic
lymphedema
melanoma
upper extremity
Journal
Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643
Informations de publication
Date de publication:
24 Sep 2024
24 Sep 2024
Historique:
received:
12
06
2024
accepted:
25
06
2024
medline:
24
9
2024
pubmed:
24
9
2024
entrez:
24
9
2024
Statut:
aheadofprint
Résumé
Lymphatic drainage from the arm may be altered after axillary lymph node dissection (ALND). Understanding these alterations is important as they may change standard surgical and radiation treatment in recurrent breast cancer or upper extremity skin cancers, including melanoma. Utilizing a single-institution planar and single photon emission computed tomography/computed tomography lymphoscintigraphy database, we identified patients with a diagnosis of upper extremity cutaneous melanoma from 2008 to 2023 who previously underwent ALND for cancer treatment and did not develop upper extremity cancer-related lymphedema. ALND patients were matched to control patients presenting with cutaneous melanomas at the same anatomic sites. Sentinel lymph nodes (SLNs) were compared between both groups. Of 3628 upper extremity melanoma cutaneous patients, 934 met inclusion criteria, including 22 ALND and 912 control patients. Level I axillary SLN drainage was observed in 98% of controls and 27% of ALND patients (p < 0.001). Level II axillary SLN drainage was observed in 3% of controls and 27% of ALND patients (p < 0.001). Level III axillary SLN drainage was observed in 1% of controls and 32% of ALND patients (p < 0.001). Epitrochlear SLN drainage was observed in 9% of controls and 32% of ALND patients, respectively (p < 0.046). Brachial SLN drainage was observed in 4% of controls and 23% of ALND patients (p < 0.001). Distinct changes in functional lymphatic drainage were seen between the arms of patients who previously underwent ALND versus control patients. Levels II and III axillary, epitrochlear, and brachial nodes are possible sites of metastatic disease that should be considered in patients with a prior ALND.
Sections du résumé
BACKGROUND
BACKGROUND
Lymphatic drainage from the arm may be altered after axillary lymph node dissection (ALND). Understanding these alterations is important as they may change standard surgical and radiation treatment in recurrent breast cancer or upper extremity skin cancers, including melanoma.
METHODS
METHODS
Utilizing a single-institution planar and single photon emission computed tomography/computed tomography lymphoscintigraphy database, we identified patients with a diagnosis of upper extremity cutaneous melanoma from 2008 to 2023 who previously underwent ALND for cancer treatment and did not develop upper extremity cancer-related lymphedema. ALND patients were matched to control patients presenting with cutaneous melanomas at the same anatomic sites. Sentinel lymph nodes (SLNs) were compared between both groups.
RESULTS
RESULTS
Of 3628 upper extremity melanoma cutaneous patients, 934 met inclusion criteria, including 22 ALND and 912 control patients. Level I axillary SLN drainage was observed in 98% of controls and 27% of ALND patients (p < 0.001). Level II axillary SLN drainage was observed in 3% of controls and 27% of ALND patients (p < 0.001). Level III axillary SLN drainage was observed in 1% of controls and 32% of ALND patients (p < 0.001). Epitrochlear SLN drainage was observed in 9% of controls and 32% of ALND patients, respectively (p < 0.046). Brachial SLN drainage was observed in 4% of controls and 23% of ALND patients (p < 0.001).
CONCLUSIONS
CONCLUSIONS
Distinct changes in functional lymphatic drainage were seen between the arms of patients who previously underwent ALND versus control patients. Levels II and III axillary, epitrochlear, and brachial nodes are possible sites of metastatic disease that should be considered in patients with a prior ALND.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : JOBST Foundation
Organisme : NHLBI NIH HHS
Pays : United States
Organisme : New Zealand Ministry of Business, Innovation and Employment
Organisme : Health Research Council of New Zealand
Organisme : University of Auckland, Strategic Research Investment Fund
Organisme : National Heart, Lung, and Blood Institute of the National Institutes of Health
ID : R01HL157991
Organisme : NIH Common Fund
ID : U54HL165440
Organisme : 2023 JOBST Lymphatic Research Grant
Organisme : Boston Lymphatic Symposium, Inc
Organisme : New Zealand Ministry of Business, Innovation and Employment 12 Labours
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524‐541. doi:10.3322/caac.21754
Ikeda T. Re‐sentinel node biopsy after previous breast and axillary surgery. Surg Today. 2014;44(11):2015‐2021. doi:10.1007/s00595-013-0783-2
Cairns C, Greenwalt I, Fan KL, Willey SC. Contralateral axillary sentinel lymph node in breast cancer recurrence. Breast J. 2020;26(7):1379‐1381. doi:10.1111/tbj.13816
Sato A, Sakai T, Iwase T, et al. Altered lymphatic drainage patterns in re‐operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence. Radiat Oncol. 2019;14(1):159. doi:10.1186/s13014-019-1367-0
Nakano S, Kakimoto S, Takahashi S, Mibu A, Saigusa H. Lymphoscintigraphy and single‐photon emission computed tomography (SPECT)/CT to determine need for second sentinel lymph node biopsy for breast cancer recurrence following ipsilateral breast/axillary surgery. Am J Case Rep. 2024;25:e942424. doi:10.12659/AJCR.942424
Roumen RMH, Kuijt GP, Liem IH. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol. 2006;32(10):1076‐1081. doi:10.1016/j.ejso.2006.08.007
Sood A, Youssef IM, Heiba SI, et al. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med. 2004;29(11):698‐702. doi:10.1097/00003072-200411000-00005
Sávolt Á, Cserni G, Lázár G, et al. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer. Eur J Surg Oncol. 2019;45(10):1835‐1838. doi:10.1016/j.ejso.2019.05.016
Moossdorff M, Vugts G, Maaskant‐Braat AJG, et al. Contralateral lymph node recurrence in breast cancer: regional event rather than distant metastatic disease. A systematic review of the literature. Eur J Surg Oncol. 2015;41(9):1128‐1136. doi:10.1016/j.ejso.2015.05.015
Ansari S, Heiba S, Mills C, Abdel‐Dayem H. Localization of the breast sentinel node after axillary node dissection with diversion of lymphatic drainage to internal mammary lymph nodes and the importance of delayed imaging. Clin Nucl Med. 2001;Jul 26(7):647‐648. doi:10.1097/00003072-200107000-00023
Ariel IM, Resnick MI. Altered lymphatic dynamics following groin and axillary dissection: its relationship to treatment policies for malignant melanoma. Surgery. 1967;61(2):210‐220.
Vugts G, Maaskant‐Braat AJG, Voogd AC, et al. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer. Breast Cancer Res Treat. 2015;153(3):549‐556. doi:10.1007/s10549-015-3571-4
Wellner R, Dave J, Kim U, Menes TS. Altered lymphatic drainage after breast‐conserving surgery and axillary node dissection: local recurrence with contralateral intramammary nodal metastases. Clin Breast Cancer. 2007;7(6):486‐488. doi:10.3816/CBC.2007.n.006
Maaskant‐Braat AJG, Voogd AC, Roumen RMH, Nieuwenhuijzen GAP. Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta‐analysis of the literature. Breast Cancer Res Treat. 2013;138(1):13‐20. doi:10.1007/s10549-013-2409-1
Johnson J, Esserman L, Ewing C, Alvarado M, Park C, Fowble B. Sentinel lymph node mapping in post‐mastectomy chest wall recurrences: influence on radiation treatment fields and outcome. Ann Surg Oncol. 2016;23(3):715‐721. doi:10.1245/s10434-015-4971-8
Maaskant‐Braat AJG, Roumen RMH, Voogd AC, et al. Sentinel node and recurrent breast cancer (SNARB): results of a nationwide registration study. Ann Surg Oncol. 2013;20(2):620‐626. doi:10.1245/s10434-012-2625-7
Karanlik H, Ozgur I, Kilic B, et al. Sentinel lymph node biopsy and aberrant lymphatic drainage in recurrent breast cancer: findings likely to change treatment decisions. J Surg Oncol. 2016;114(7):796‐802. doi:10.1002/jso.24423
Tokmak H, Kaban K, Muslumanoglu M, Demirel M, Aktan S. Management of sentinel node re‐mapping in patients who have second or recurrent breast cancer and had previous axillary procedures. World J Surg Oncol. 2014;12:205. doi:10.1186/1477-7819-12-205
Koizumi M, Koyama M, Tada K, et al. The feasibility of sentinel node biopsy in the previously treated breast. Eur J Surg Oncol. 2008;34(4):365‐368. doi:10.1016/j.ejso.2007.04.007
Guru SD, Hoskin TL, Whaley DH, Nathan MA, Jakub JW. Repeat sentinel lymph node surgery in recurrent breast cancer: peritumoral vs. periareolar injections. Clin Breast Cancer. 2021;21(5):466‐476. doi:10.1016/j.clbc.2021.02.004
Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Cutaneous melanoma. Lancet. 2023;402(10400):485‐502. doi:10.1016/S0140-6736(23)00821-8
Johnson C, Intenzo C, Mastrangelo MJ, Feeney K, Berger AC. Altered drainage patterns in patients with melanoma and previous axillary dissection. J Dermatol. 2013;40(7):564‐566. doi:10.1111/1346-8138.12143
Miranda EP, Bellevue OC, Leong SP. Reoperative selective sentinel lymphadenectomy combined with lymphoscintigraphy is technically feasible for cutaneous tumors of the upper extremity after radical dissection of regional lymph node basins for breast cancer. Eplasty. 2014;14:32.
Uren RF, Thompson JF, Howman‐Giles R. Lymphatic Drainage of the Skin and Breast: Locating the Sentinel Nodes. Harwood Academic; 1999.
Reynolds HM, Dunbar PR, Uren RF, Thompson JF, Smith NP. Mapping melanoma lymphoscintigraphy data onto a 3D anatomically based model. Ann Biomed Eng. 2007;35(8):1444‐1457. doi:10.1007/s10439-007-9315-9
Reynolds HM, Dunbar PR, Uren RF, Blackett SA, Thompson JF, Smith NP. Three‐dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma. Lancet Oncol. 2007;8(9):806‐812. doi:10.1016/S1470-2045(07)70176-6
Reynolds HM, Smith NP, Uren RF, Thompson JF, Dunbar PR. Three‐dimensional visualization of skin lymphatic drainage patterns of the head and neck. Head Neck. 2009;31(10):1316‐1325. doi:10.1002/hed.21089
Ackerman MJ. The visible human project. Proc IEEE. 1998;86:504‐511.
Coroneos CJ, Woodward WA, Wong FC, et al. Anatomy and physiology of the sentinel lymph nodes of the upper extremity: implications for axillary reverse mapping in breast cancer. J Surg Oncol. 2021;123(4):846‐853. doi:10.1002/jso.26343
Wang W, Ward R, Jia D, et al. Location of arm draining lymph node in relation to breast cancer radiotherapy field and target volume. Radiother Oncol. 2019;133:193‐197. doi:10.1016/j.radonc.2018.10.038
Sarri AJ, Dias R, Laurienzo CE, Gonçalves MCP, Dias DS, Moriguchi SM. Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer. Onco Targets Ther. 2017;10:1451‐1457. doi:10.2147/OTT.S117830
Teixeira F, Akaishi E, Mendes G, Moutinho V, Utiyama E, Rasslan S. Mid‐humeral sentinel lymph node dissection in patients with primary cutaneous malignant melanoma. Melanoma Res. 2010;20(2):138‐140. doi:10.1097/CMR.0b013e328335053c
Cheville AL, Das I, Srinivas S, et al. A pilot study to assess the utility of SPECT/CT‐based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer. Breast Cancer Res Treat. 2009;116(3):531‐538. doi:10.1007/s10549-008-0283-z
Johnson AR, Bravo MG, James TA, Suami H, Lee BT, Singhal D. The all but forgotten Mascagni‐Sappey pathway: learning from immediate lymphatic reconstruction. J Reconstr Microsurg. 2020;36(1):28‐31. doi:10.1055/s-0039-1694757
Kim G, Johnson AR, Hamaguchi R, Adondakis M, Tsai LL, Singhal D. Breast cancer‐related lymphedema: magnetic resonance imaging evidence of sparing centered along the cephalic vein. J Reconstr Microsurg. 2021;37(6):519‐523. doi:10.1055/s-0040-1722648
Friedman R, Bustos VP, Pardo J, et al. Superficial and functional imaging of the tricipital lymphatic pathway: a modern reintroduction. Breast Cancer Res Treat. 2023;197(1):235‐242. doi:10.1007/s10549-022-06777-z
Abdelfattah U, Jaimez PM, Clavero JA, Bellantonio V, Pons G, Masia J. Correlation between superficial and deep lymphatic systems using magnetic resonance lymphangiography in breast cancer‐related lymphedema: clinical implications. J Plast Reconstr Aesthet Surg. 2020;73(6):1018‐1024. doi:10.1016/j.bjps.2019.11.053
Ma X, Wen S, Liu B, et al. Relationship between upper extremity lymphatic drainage and sentinel lymph nodes in patients with breast cancer. J Oncol. 2019;2019:1‐7. doi:10.1155/2019/8637895
Suami H, Pan WR, Taylor GI. Changes in the lymph structure of the upper limb after axillary dissection: radiographic and anatomical study in a human cadaver. Plast Reconstr Surg. 2007;120(4):982‐991. doi:10.1097/01.prs.0000277995.25009.3e
Suami H, Scaglioni M. Anatomy of the lymphatic system and the lymphosome concept with reference to lymphedema. Semin Plast Surg. 2018;32(1):5‐11. doi:10.1055/s-0038-1635118
Koelmeyer LA, Thompson BM, Mackie H, et al. Personalizing conservative lymphedema management using indocyanine green‐guided manual lymphatic drainage. Lymphat Res Biol. 2021;19(1):56‐65. doi:10.1089/lrb.2020.0090
Mascagni P. Vasorum Lymphaticorum Corporis Humani. Historia & Iconographia. Historia & Iconographia. Pazini Carli. 1787. Accessed February 1, 2024. http://anatomia.library.utoronto.ca/islandora/object/anatomia%3ARBAI052
Sappey PC. Anatomie, Physiologie, Pathologie des Vesseaux Lymphatiques Consideres Chez L'homme et les Vertebres. Paris A. 1885. Accessed February 1, 2024. http://ci.nii.ac.jp/naid/10012361149/
Kubik S. The role of the lateral upper arm bundle and the lymphatic watersheds in the formation of collateral pathways in lymphedema. Acta Biol Acad Sci Hung. 1980;31:191‐200.
Leduc A, Caplan I, Leduc O. Lymphatic drainage of the upper limb. Substitution lymphatic pathways. Eur J Lymphol Relat Probl. 1993;4:11‐18.
Johnson AR, Granoff MD, Suami H, Lee BT, Singhal D. Real‐time visualization of the Mascagni‐Sappey pathway utilizing ICG lymphography. Cancers. 2020;12:1195. doi:10.3390/cancers12051195
Granoff MD, Pardo J, Shillue K, et al. Variable anatomy of the lateral upper arm lymphatic channel: a potential anatomic risk factor for the development of breast cancer related lymphedema. Plast Reconstr Surg. 2023;152(2):422‐429. doi:10.1097/PRS.0000000000010245
Mikami T, Koyama A, Hashimoto K, et al. Pathological changes in the lymphatic system of patients with secondary upper limb lymphoedema. Sci Rep. 2019;9(1):8499. doi:10.1038/s41598-019-44735-w